A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
Clinical trial NCT01332968 · COMPLETED
Trial details
- NCT number
- NCT01332968
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-06
- Primary completion
- 2016-02-01
- Enrollment
- 1401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.